What is Sales and Marketing Strategy of Demant Company?

Demant Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

How does Demant win customers with its premium hearing-care strategy?

Demant shifted to premium rechargeable devices and remote care from 2019–2021, boosting ASPs and digital engagement while gaining market share. Its full-stack model spans hearing aids, implants, diagnostics, communications, and retail across 30+ countries.

What is Sales and Marketing Strategy of Demant Company?

Demant sells via clinics, distributor networks, owned retail, omnichannel DTC, insurer partnerships, and hospital/ENT channels, leveraging teleaudiology and data-driven marketing to position 'brain-first' premium care.

See strategic context and competitive dynamics in Demant Porter's Five Forces Analysis.

How Does Demant Reach Its Customers?

Sales Channels for Demant combine a large owned retail clinic network with partner audiologists, B2B diagnostics, managed-care pathways and growing omnichannel digital touchpoints to capture prescription and consumer demand across North America, Europe and select APAC/LatAm markets.

Icon Integrated retail clinics

Demant operates one of the world’s largest hearing-care retail networks with thousands of clinics across North America and Europe; retail drives fitting, follow-up, subscriptions and trade-ins and expanded post-2020 to capture OTC interest while funneling prescription candidates.

Icon Partner audiologists & distributors

Where retail density is lower, Demant sells via independent audiologists, hospitals and distributors—important in DACH, parts of APAC/LatAm and public-tender environments—to balance reach with brand control and support mid-premium tiers.

Icon Managed care & payors

In the U.S., insurer/TPA relationships, veterans channels and Medicare Advantage pathways now cover roughly 35–40% of hearing-aid units; Demant uses in-network coverage to sustain volume while pursuing premium upsell since 2022.

Icon E‑commerce & DTC enablement

Demant expanded online screening, appointment booking, remote fine‑tuning and accessory sales; post-2022 omnichannel pilots (click-to-clinic, remote refits, subscriptions) made online-to-offline conversion a material new-patient source in the U.S. and Nordics.

Additional channels include consumer adjacencies, diagnostics and implants supported by direct sales and distributor networks, and strategic supplier/partnership deals that raise clinic lifetime value and market share.

Icon

Channel facts and strategic moves

Recent strategic shifts emphasize omnichannel integration, CRM-driven recall, partnerships with insurers and employer programs, and selective retail adjacencies while prioritizing medical-grade prescription devices.

  • Retail clinics: primary revenue engine; same-store sales benefited from premium mix and rechargeable adoption post-2020.
  • Diagnostics growth: mid-to-high single digits, buoyed by replacement cycles and newborn screening mandates.
  • EPOS and accessories: B2C channels for gaming/enterprise headsets and battery/accessory sales, supporting brand adjacency.
  • Public tenders & KOL engagement: implants and institutional diagnostics sold via tenders and surgical-center partnerships.

For context on competitive positioning and market dynamics related to Demant’s sales and marketing strategy, see Competitors Landscape of Demant

Demant SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

What Marketing Tactics Does Demant Use?

Marketing Tactics for Demant focus on integrated digital and offline activation to drive clinic leads, post-sale engagement, and clinician adoption across global markets, using data-driven targeting and HIPAA/GDPR-compliant personalization.

Icon

Digital demand engine

SEO-optimized educational content on hearing loss, tinnitus and cognition funnels organic traffic; localized clinic pages and online hearing tests convert visits into booked screenings.

Icon

Paid performance channels

Google and Meta campaigns target 55+ consumers and caregivers with intent-based bidding and call-tracking; paid search drives high-intent leads and local appointment volume.

Icon

Teleaudiology & CRM

Remote fitting via Oticon apps and CRM/CDP segmentation (hearing profile, device age, warranty) enable recalls, battery reminders and upgrade prompts at 24–36 months.

Icon

Content & clinician outreach

White papers, HCP webinars and KOL case studies on neural network processing and listening effort reduction support clinic adoption and diagnostic partnerships.

Icon

Traditional & community

Regional TV/radio and direct mail target high 65+ markets; screenings, health fairs and physician referral programs sustain grassroots acquisition and clinic throughput.

Icon

Influencers & partnerships

Caregiver and healthy-aging creators on YouTube/Facebook boost awareness; EPOS and esports/UC partnerships extend audio credibility into new segments.

Icon

Analytics, experimentation & spend shift

Attribution blends call-tracking, web-to-appointment conversions, CRM-matched revenue and media-mix modeling; geotargeting and LTV-based bidding optimize clinic ROI. Since 2022, media spend shifted approximately 10–20 percentage points toward digital performance channels with stronger first-party data controls and HIPAA/GDPR compliance.

  • SEO content drives top-funnel education and supports demant marketing strategy and demant go-to-market approach.
  • Paid search/social use intent bidding and call-tracking to measure demant sales strategy effectiveness in local markets.
  • CRM/CDP triggers increase show-rates, reduce no-shows and prompt upgrades consistent with demant company strategy for aftercare.
  • Experimentation includes conversational AI pre-qualification, localized landing pages and LTV-based bidding to improve demant digital marketing strategy for medical devices.

See further context on corporate direction in Mission, Vision & Core Values of Demant.

Demant PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

How Is Demant Positioned in the Market?

Demant positions Oticon and sister brands as premium, brain-first hearing solutions that prioritize natural sound, reduced listening effort, and seamless connectivity, differentiating through on-device intelligence and clinical outcomes rather than simple amplification.

Icon Core positioning

Emphasizes the brain’s role in hearing via an open sound paradigm and deep neural networks to preserve auditory scenes for easier conversation in complex environments; messaging targets clinicians and outcome-focused users.

Icon Visual & tonal identity

Clean, medical-grade premium visuals with approachable multigenerational photography; tone is empathetic, science-backed, and confidence-giving to reduce stigma and support uptake.

Icon Customer experience promise

End-to-end professional care: precise fitting, remote support, rechargeable systems to cut disposable battery waste, easy maintenance, and clear warranties/financing to boost conversion and loyalty.

Icon EPOS positioning

Anchored on enterprise-grade audio clarity and ergonomic design for hybrid work and gaming, extending Demant’s premium engineering into headsets and professional audio solutions.

Icon

Clinical differentiation

Focuses on clinical outcomes and validated algorithms; uses trials, satisfaction guarantees, and published studies to counter OTC and CE brand threats and support clinician adoption.

Icon

Omnichannel consistency

Maintains cohesive presence across clinic signage, websites, apps, packaging, and HCP materials to reinforce trust in Demant sales strategy and demant marketing strategy globally.

Icon

Sustainability & product design

Rechargeable ecosystems reduce disposable battery waste; award-winning device and app design bolster perception—industry awards cited in 2023–2024 support market credibility.

Icon

Target audiences

Appeals to innovation- and outcome-seeking consumers and clinicians; segmentation includes digitally engaged seniors, audiology clinics, and enterprise users for hybrid work solutions.

Icon

Go-to-market tactics

Combines B2B clinic partnerships, training and sales enablement for audiologists, omnichannel retail and direct channels; trial programs and warranties increase adoption versus OTC competitors.

Icon

Metrics & impact

Clinical validation and app UX awards drive clinician referrals; Demant reported hearing solutions revenue growth and increased service attach rates in 2024, supporting the demant company strategy and demant go-to-market approach.

Icon

Key positioning elements

Positioning balances science, care and lifestyle to defend premium market share and adapt to sentiment shifts.

  • Emphasize brain-first tech and clinical outcomes to differentiate from amplification-focused rivals.
  • Showcase rechargeable ecosystems and sustainability to resonate with EU consumers.
  • Leverage awards and published studies for HCP trust and consumer credibility.
  • Align EPOS messaging to enterprise and gaming performance needs while keeping premium visual identity.

Revenue Streams & Business Model of Demant

Demant Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What Are Demant’s Most Notable Campaigns?

Key campaigns of the company emphasize science-led product launches, omnichannel lead-gen and reputation reinforcement to drive premium mix, clinician adoption and steady top-of-funnel growth.

Icon Oticon More launch (2021)

Objective: position DNN-powered 'brain-first' benefits through real-life soundscape creative; channels included EUHA/AAA, YouTube pre-roll, paid search, clinician toolkits and PR. Results: accelerated premium mix, higher ASPs and awards-driven clinician adoption; app-enabled trials and KOL advocacy were decisive success factors.

Icon Oticon Real (2023) & Oticon Intent (2024)

Objective: improve wind/handling noise and user-intent detection with outdoor lifestyle creative and in-store/online demos; channels: clinic events, social video, influencers and targeted recalls. Results: double-digit Hearing Healthcare organic growth in 2024, premium share gains and higher upgrade rates; targeted recalls plus situational demos lifted conversion.

Icon HearingLife 'Free Hearing Check' & screenings

Objective: top-of-funnel lead generation framed as health-and-wellness to reduce stigma; channels: local TV/radio, direct mail, Meta lead ads and clinic landing pages with online booking. Results: sustained appointment growth, improved show rates via SMS reminders and lower cost-per-lead through geo-targeting; omnichannel O2O integration was key.

Icon EPOS enterprise & gaming partnerships

Objective: broaden audio leadership with productivity and competitive-edge narratives; channels included LinkedIn, B2B events, esports sponsorships and Amazon storefronts. Results: enhanced brand visibility beyond medical hearing, supporting cross-category credibility and consumer trust in hearing tech.

Icon

Reputation & trust reinforcement

Objective: preserve credibility amid OTC and macro pressures using clinical outcomes, satisfaction guarantees and clear financing; channels: PR, clinic comms and insurer co-marketing. Results: stable conversion and retention, mitigating pricing pressure; transparency maintained premium positioning.

Icon

Channels & trade-up mechanics

Clinic events, targeted recalls to 24–36 month cohorts, influencer testimonials and app trials consistently increased upgrade rates and ASPs; clinician toolkits and KOL advocacy amplified product positioning in distribution channels.

Icon

Measurable outcomes

By 2024 campaigns delivered double-digit organic growth in Hearing Healthcare, higher premium share and improved show/appointment rates; investment in demo-enabled selling drove meaningful conversion uplifts and trade-up percentages.

Icon

Success factors

Science-backed storytelling, app-enabled trials, omnichannel O2O execution and robust KOL/clinician advocacy are repeatedly cited as critical to campaign effectiveness and distribution partner buy-in.

Icon

Strategic lesson

Adjacent-category authority (EPOS partnerships) and clear reputation tactics sustain premium pricing and support demant sales strategy, demant marketing strategy and demant go-to-market approach across clinics and retail.

Icon

Further reading

See market targeting detail in Target Market of Demant for alignment with demant product positioning and demant distribution channels.

Demant Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.